Autoimmune Disease Clinical Trials 2023

Autoimmune Disease Clinical Trials 2023

Autoimmune Disease research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in autoimmune disease clinical trials today.

Autoimmune Disease Clinical Trials

Here are the 6 most popular medical studies for autoimmune disease

Popular filter options for autoimmune disease trials

Multiple Sclerosis Clinical Trials

View 21 Multiple Sclerosis medical studies.

Autoimmune Diseases Clinical Trials

View 19 Autoimmune Diseases medical studies.

Autoimmune Disease Clinical Trials With No Placebo

View 24 autoimmune disease medical studies that do not have a placebo group.

View More Autoimmune Disease Trials

See another 8 many medical studies focused on autoimmune disease.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to autoimmune disease

What are the top hospitals conducting autoimmune disease research?

When it comes to cutting-edge clinical trials in the field of autoimmune diseases, several top hospitals are making significant strides. Massachusetts General Hospital in Boston leads the pack with three active trials and a total of seven completed trials focused on these complex conditions. This renowned institution has been at the forefront of autoimmune disease research since recording its first trial in 2005.

Meanwhile, Mayo Clinic located in Rochester, Minnesota is another respected center for medical innovation. With two ongoing autoimmune disease trials and a total of four completed studies, Mayo Clinic entered this arena in 2010 and has been actively contributing ever since.

The National Institutes of Health (NIH) Clinical Center located in Bethesda, Maryland also plays a vital role in advancing our understanding and treatment options for autoimmune diseases. Currently conducting two active clinical trials for these conditions, NIH has recorded five previous studies since initiating their first trial back in 2009.

In New York City's prestigious Hospital for Special Surgery, researchers are focusing on exploring novel interventions for individuals suffering from autoimmune diseases. With two ongoing clinical trials and a record of three previously conducted studies from their inaugural exploration launched just four years ago in 2017; they have quickly made their mark within this specialized field.

Lastly but by no means least University of Alberta situated within Edmonton takes pride as it pioneers new paths towards treating autoimmune disorders with one currently running trial while already managing to hold credit completing not only trialing experiments but being able commenced those endeavors as well starting merely early this year during2022 .

These esteemed institutions highlight the dedication and commitment to finding effective treatments for individuals affected by various forms of autoimmunity across North America. Through rigorous research efforts like these clinical trials, scientists strive to uncover breakthroughs that will ultimately lead us closer to improved management strategies or even cures for these often life-altering conditions

Which are the best cities for autoimmune disease clinical trials?

Boston, Massachusetts; New York, New York; Saint Louis, Missouri; Bethesda, Maryland; and Philadelphia, Pennsylvania; New York, New York; Saint Louis, Missouri; Bethesda, Maryland; and Philadelphia, Pennsylvania are among the top cities for autoimmune disease clinical trials. These cities have a significant number of active studies aimed at advancing treatments for various autoimmune conditions. With varying numbers of ongoing trials and diverse investigational approaches such as Nivolumab, Rituximab Infusion, and Oral Ifetroban, these cities offer individuals with autoimmune diseases access to cutting-edge research opportunities that may ultimately lead to improved management options and better quality of life.

Which are the top treatments for autoimmune disease being explored in clinical trials?

The world of autoimmune disease research is constantly evolving, and there are a few standout treatments that have shown promise in recent clinical trials. Peresolimab has emerged as a frontrunner, currently being studied in one active trial for autoimmune disease. Although it's relatively new to the scene with only one all-time trial since its listing in 2022, peresolimab holds great potential for patients seeking effective treatment options. Another contender making waves is Diamyd, which also boasts one active trial and has been involved in two all-time trials since its introduction in 2017. As researchers delve deeper into these innovative therapies, hope continues to grow for those living with autoimmune diseases worldwide.

What are the most recent clinical trials for autoimmune disease?

Promising advancements in the field of autoimmune disease have emerged through recent clinical trials. One notable study explores the potential benefits of depleting CD3/CD19 during autologous stem cell transplants. This Phase 2 trial, available since September 1, 2023, aims to uncover new approaches for treating autoimmune diseases. Another trial investigates KYV-101 CAR-T cells with lymphodepletion conditioning in Phase 1. By utilizing this innovative method along with comprehensive monitoring and evaluation, researchers hope to develop effective therapies against autoimmune diseases. Additionally, VCTX211 unit is undergoing combined Phase 1 and Phase 2 trials as of January 20, 2023—a significant step towards enhancing treatment options for those affected by these challenging conditions. With these groundbreaking studies paving the way forward, patients living with autoimmune diseases can look toward a future marked by improved outcomes and quality of life.

What autoimmune disease clinical trials were recently completed?

Recent clinical trials have made significant strides in the field of autoimmune disease research. Notably, a trial sponsored by CRISPR Therapeutics AG concluded in January 2022, exploring the potential of VCTX210A unit as a treatment option. Additionally, Suzhou Connect Biopharmaceuticals' CBP-307 underwent successful testing and completed its trial in June 2021. It is worth mentioning that Bristol-Myers Squibb's branebrutinib study reached completion back in January 2020. These developments highlight ongoing efforts to advance our understanding and treatment options for autoimmune diseases, providing hope for patients worldwide facing these conditions.